Hospital directory
Ruijin Hospital
Shanghai (Huangpu District) · Last verified: 2026-09-09
One of China's most prestigious public hospitals, affiliated with Shanghai Jiao Tong University School of Medicine. Its hematology institute produced the 'Shanghai protocol' for acute promyelocytic leukemia, and in 2021 Ruijin issued China's first commercial CAR-T prescription.
- Type
- Public, grade-A tertiary (founded 1907)
- Website
- www.rjh.com.cn Official site is Chinese only — no English version as of last verification
CAR-T program — documented facts
-
Issued China's first commercial CAR-T prescription on 2021-06-28 (axicabtagene ciloleucel); the first commercial patient was discharged in complete remission (state media)
-
Shanghai Institute of Hematology: decades of internationally recognized leukemia research (ATRA + arsenic 'Shanghai protocol' for APL)
-
Ongoing CAR-T clinical research documented in peer-reviewed publications
International patients
- International services
- Listed on the Shanghai government International Medical Services portal: 197 Ruijin Er Road, Huangpu; phone 021-6467-8970 (Mon–Sat)
- Language
- Official site Chinese only; English-language support level is not officially documented
- Pricing
- No public international price list; national list price of the first commercial product was ~RMB 1.2M (state media, 2021)
What we could not verify
-
Current intake process and English support for self-directed international patients — confirm directly with the hospital
Sources
Directory pages compile documented public information for orientation. They are not endorsements, rankings, or medical advice.